AKUMS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Akums Drugs and Pharmaceuticals Ltd reported sales of ₹1,342 Cr, operating profit of ₹195 Cr (OPM 15%) and net profit of ₹115 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
AKUMS quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
1,010
1,056
1,024
1,018
1,160
1,158
1,167
1,342
Expenses
889
962
895
923
1,013
1,006
992
1,148
Operating Profit
121
94
129
94
147
152
175
195
OPM
12%
9%
13%
9%
13%
13%
15%
15%
Other Income
19
26
27
32
16
34
30
29
Interest
5
5
23
23
24
24
25
26
Depreciation
45
40
37
38
40
40
41
43
Profit before tax
91
75
96
66
100
121
139
155
Tax
27%
-99%
32%
35%
32%
33%
27%
26%
Net Profit
66
150
65
43
68
81
101
115
EPS in Rs
4.14
9.38
4.03
2.59
4.21
5.38
6.35
7.17
AKUMS profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
3,672
3,655
4,178
4,118
4,359
4,826
Expenses
3,761
3,361
4,055
3,654
3,837
4,158
Operating Profit
-89
294
123
465
522
668
OPM
-2.4%
8%
3%
11%
12%
14%
Other Income
7
15
8
69
108
109
Interest
17
46
51
35
94
98
Depreciation
95
113
126
153
155
164
Profit before tax
-193
150
-45
345
382
515
Tax
30%
35%
-102%
0%
33%
-
Net Profit
-251
98
1
344
256
365
EPS in Rs
-17.65
6.63
-0.28
21.49
16.21
23.11
Dividend Payout
0%
0%
0%
0%
18%
-
AKUMS balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
29
31
31
31
31
Reserves
681
3,016
3,118
3,283
3,472
Borrowings
565
88
90
157
117
Other Liabilities
2,229
960
1,920
1,958
2,212
Total Liabilities
3,504
4,095
5,159
5,429
5,832
Fixed Assets
1,191
1,397
1,421
1,456
1,536
CWIP
195
163
158
177
246
Investments
0
0
0
0
71
Other Assets
2,118
2,535
3,580
3,796
3,979
Total Assets
3,504
4,095
5,159
5,429
5,832
AKUMS cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
32
177
498
465
1,181
Cash from Investing Activity
-235
-305
-331
-548
-930
Cash from Financing Activity
236
125
-108
73
34
Net Cash Flow
33
-4
59
-10
285
Free Cash Flow
-224
-110
212
201
958
CFO/OP
-98%
93%
455%
118%
243%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit